Common Anti-Inflammatory Drugs May Help Flu and COVID Viruses Spread, Study Warns

A recent study published in the journal NAR Molecular Medicine by scientists at the Norwegian University of Science and Technology (NTNU) suggests that certain anti-inflammatory medications, specifically Janus kinase (JAK) inhibitors, may weaken the body's immune defenses and help viruses spread more easily.

Researchers reported that these medications, which are often prescribed for autoimmune and inflammatory conditions like rheumatoid arthritis, can suppress key immune signaling pathways. According to the study authors, this calming effect on the immune system may inadvertently make the body more vulnerable to viral infections.

Key Findings from the Research

• Affected Pathogens: The study found that drugs such as baricitinib can facilitate the spread of viruses including influenza A, SARS-CoV-2 (the virus that causes COVID-19), adenovirus, and Rift Valley fever virus.
• Suppressed Defenses: JAK inhibitors were observed to suppress the activity of genes that normally respond to viral threats, weakening natural cellular protections.
• Study Scope: Researchers examined laboratory-created mini-organs and cells from human lungs, eyes, and brain.

Practical Implications and Precautions

Study authors noted that these findings highlight a potential hidden risk for patients with latent or active viral infections. However, the researchers emphasized that these are laboratory findings and do not constitute a clinical directive to stop prescribing the medications.

• Consult Your Doctor: Patients taking JAK inhibitors should not stop taking them or alter their dosage without first consulting a qualified healthcare professional.
• Medical Caution: The researchers suggested that healthcare providers exercise caution when prescribing these drugs during viral outbreaks.
• Need for Further Study: Additional research is recommended to better understand how to optimize the use of these medications during pandemics or viral outbreaks.

To verify the original findings, readers can review the published study in the journal NAR Molecular Medicine or read the press release issued by the Norwegian University of Science and Technology.